CV Sciences, Inc. CVSI received a formal certificate of grant from the Japan Patent Office for its patent application 7216697. The patent covers methods for treating smokeless tobacco addiction by ...

NEW YORK, June 23, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with ...

SAN DIEGO, March 23, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company ...

Tobacco kills more than seven million people each year, including more than one million non-smokers who are exposed to ...

Indiana's recent tobacco tax increase creates an opportunity to address the combined challenge of tobacco and opioid addiction. People with substance use disorders, including those in treatment for ...